Literature DB >> 18473098

Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study.

Mu-Jen Shih1, Nan-Yao Lee, Hsin-Chun Lee, Chia-Ming Chang, Chi-Jung Wu, Po-Ling Chen, Nai-Ying Ko, Wen-Chien Ko.   

Abstract

BACKGROUND AND
PURPOSE: Acinetobacter baumannii is an important nosocomial pathogen. Bacteremia caused by multidrug-resistant A. baumannii (MDRAB) leads to higher mortality and medical cost compared with non-MDRAB bacteremia. We aimed to identify risk factors of multidrug resistance in A. baumannii bacteremia.
METHODS: A matched case-control study was conducted to compare the differences in risk factors of patients with MDRAB and non-MDRAB bacteremia.
RESULTS: Sixty three patients with MDRAB bacteremia and 63 matched patients with non-MDRAB bacteremia were identified from hospital and laboratory records of the period 1996 to 2002. Multivariate logistic regression analysis identified four independent risk factors associated with multidrug resistance in A. baumannii bacteremic patients: previous colonization with A. baumannii (odds ratio [OR], 7.99; 95% confidence interval [CI], 2.1-30.6; p=0.002), antecedent antimicrobial therapy (OR, 6.10; 95% CI, 1.2-29.9; p=0.026) the number of recently prescribed antibiotics (OR 1.35; 95% CI, 1.0-1.8; p=0.026), and recent invasive procedures (OR, 4.17; 95% CI, 1.6-11.1; p=0.004).
CONCLUSIONS: Overall, patients with MDRAB bacteremia had earlier A. baumannii colonization, greater previous exposure to antimicrobial agents and recent invasive procedures. The results of this study demonstrate a rationale for the development of effective interventions to minimize the impact of MDRAB.

Entities:  

Mesh:

Year:  2008        PMID: 18473098

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  12 in total

1.  Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.

Authors:  Sarah Ainsworth; Patrick M Ketter; Jieh-Juen Yu; Rose C Grimm; Holly C May; Andrew P Cap; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  Vaccine       Date:  2017-05-15       Impact factor: 3.641

2.  Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Authors:  C Routsi; M Pratikaki; E Platsouka; C Sotiropoulou; S Nanas; V Markaki; C Vrettou; O Paniara; H Giamarellou; C Roussos
Journal:  Infection       Date:  2010-03-12       Impact factor: 3.553

3.  Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene.

Authors:  V C C Cheng; J H K Chen; R W S Poon; W M Lee; S Y C So; S C Y Wong; P H Chau; C C Y Yip; S S Y Wong; J F W Chan; I F N Hung; P L Ho; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

4.  Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents.

Authors:  Tingting Zhang; Min Wang; Yixin Xie; Xianping Li; Zhihui Dong; Yanhua Liu; Ling Wang; Min Yang; Huan Song; Hong Cao; Wei Cao
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

5.  The dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Haemophilus influenzae contains two active-site histidine residues.

Authors:  Danuta M Gillner; David L Bienvenue; Boguslaw P Nocek; Andrzej Joachimiak; Vincentos Zachary; Brian Bennett; Richard C Holz
Journal:  J Biol Inorg Chem       Date:  2008-08-19       Impact factor: 3.358

6.  Incidence, impact and risk factors for multidrug-resistant organisms (MDRO) in patients with major trauma: a European Multicenter Cohort Study.

Authors:  André Nohl; Uwe Hamsen; Kai Oliver Jensen; Kai Sprengel; Franziska Ziegenhain; Rolf Lefering; Marcel Dudda; Thomas Armin Schildhauer; Alexander Wegner
Journal:  Eur J Trauma Emerg Surg       Date:  2020-11-22       Impact factor: 3.693

7.  Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit.

Authors:  Ji Ye Jung; Moo Suk Park; Song Ee Kim; Byung Hoon Park; Ji Young Son; Eun Young Kim; Joo Eun Lim; Sang Kook Lee; Sang Hoon Lee; Kyung Jong Lee; Young Ae Kang; Se Kyu Kim; Joon Chang; Young Sam Kim
Journal:  BMC Infect Dis       Date:  2010-07-30       Impact factor: 3.090

8.  The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit.

Authors:  Wei-Lun Liu; Hsueh-Wen Liang; Mei-Feng Lee; Hsin-Lan Lin; Yu-Hsiu Lin; Chi-Chung Chen; Ping-Chin Chang; Chih-Cheng Lai; Yin-Ching Chuang; Hung-Jen Tang
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 9.  Bacterial contamination of inanimate surfaces and equipment in the intensive care unit.

Authors:  Vincenzo Russotto; Andrea Cortegiani; Santi Maurizio Raineri; Antonino Giarratano
Journal:  J Intensive Care       Date:  2015-12-10

Review 10.  Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria.

Authors:  Vincenzo Russotto; Andrea Cortegiani; Giorgio Graziano; Laura Saporito; Santi Maurizio Raineri; Caterina Mammina; Antonino Giarratano
Journal:  Infect Drug Resist       Date:  2015-08-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.